Powerful Intelligence for Dealmakers
Distribution and marketing agreement for products
| Companies: |
Pfizer Shanghai Pharmaceutical |
|---|---|
| Announcement date: | Apr 20 2011 |
| Deal value, US$m: | n/d |
Details
| Announcement date: | Apr 20 2011 |
|---|---|
| Industry sectors: |
Bigpharma
Pharmaceutical |
| Deal components: |
Distribution
Marketing |
| Stages of development: |
Marketed
|
| Geographic focus: |
Asia
»
China
|
Financials
| Deal value, US$m: | n/d |
|---|
Termsheet
Pfizer have signed a memorandum of understanding to explore a broad range of mutual projects in China.
The immediate goal is to give Shanghai Pharma the responsibility for registering and marketing an unspecified innovative Pfizer drug.
MOU envisions deepening the relationship between the two companies, including possible equity investments.
Press Release
Shanghai Pharma and Pfizer Sign MOU to Expand Collaboration
publication date: Apr 21, 2011
Shanghai Pharmaceutical and Pfizer have signed a memorandum of understanding to explore a broad range of mutual projects in China. The immediate goal is to give Shanghai Pharma the responsibility for registering and marketing an unspecified innovative Pfizer drug. But the MOU envisions deepening the relationship between the two companies, including possible equity investments.
Filing Data
Not available.
Contract
Not available.